Advertisement

Precipio, Inc. PRPO

Set alert

Price alert · PRPO

All alert types
18.10 USD -1.25 -6.46%

At close · Oct 30

18.10 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
18.05 × 1
Ask
18.30 × 1
17.99 Day range 19.83
18.10 52-week range 32.37
YTD
-21.24%
1 year
-11.58%
Open
19.83
Prev close
19.35
Mkt cap
32.40M
Vol
25.90K
Avg vol
105.51K
EPS
-0.64
P/E
0.00
Div yield
0.00%
More statistics
Low
17.99
High
19.83
Forward P/E
13.34
Beta
1.42
Short ratio
0.59
Inst. own
8.79%
Dividend
0.00
Ex-div date
50-d avg
6.13
200-d avg
5.98
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 6, 2024Earnings: -0.42; estimate 0; surprise —%
Signals (89)
NameDateAgo
RSI: OversoldOct 30, 20261 day ago
RSI: OversoldOct 23, 20261 week ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
MACD: Sell SignalSep 2, 20261 month ago
RSI: OverboughtAug 19, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 10, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BearishJul 20, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
SMA: BullishJul 17, 20263 months ago
SMA: BullishJul 17, 20263 months ago
MACD: Buy SignalJul 17, 20263 months ago
SMA: BearishJul 16, 20263 months ago
SMA: BearishJul 16, 20263 months ago
MACD: Sell SignalJul 16, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BearishJul 10, 20263 months ago
SMA: BearishJul 10, 20263 months ago
SMA: BullishJul 7, 20263 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 9, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BearishMay 15, 20265 months ago
MACD: Sell SignalMay 8, 20265 months ago
MACD: Buy SignalApr 27, 20266 months ago
MACD: Sell SignalApr 21, 20266 months ago
MACD: Buy SignalApr 8, 20266 months ago
SMA: BullishApr 2, 20267 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BearishMar 30, 20267 months ago
MACD: Sell SignalMar 23, 20267 months ago
SMA: BullishFeb 26, 20268 months ago
SMA: BullishFeb 20, 20268 months ago
SMA: BearishFeb 19, 20268 months ago
SMA: BullishFeb 18, 20268 months ago
MACD: Buy SignalFeb 17, 20268 months ago
RSI: OversoldFeb 9, 20268 months ago
SMA: BearishFeb 4, 20268 months ago
MACD: Sell SignalJan 29, 20269 months ago
MACD: Buy SignalJan 20, 20269 months ago
MACD: Sell SignalJan 16, 20269 months ago
MACD: Buy SignalJan 12, 20269 months ago
MACD: Sell SignalDec 9, 202510 months ago
RSI: OverboughtNov 19, 202511 months ago
MACD: Buy SignalNov 18, 202511 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BearishNov 14, 202511 months ago
MACD: Sell SignalNov 3, 202512 months ago
MACD: Buy SignalOct 22, 20251 year ago
SMA: BullishOct 15, 20251 year ago
SMA: BearishOct 14, 20251 year ago
MACD: Sell SignalOct 8, 20251 year ago
MACD: Buy SignalOct 2, 20251 year ago
MACD: Sell SignalSep 17, 20251 year ago
RSI: OverboughtSep 4, 20251 year ago
MACD: Buy SignalAug 28, 20251 year ago
MACD: Sell SignalJul 18, 20251 year ago
MACD: Buy SignalJul 7, 20251 year ago
RSI: OverboughtJul 7, 20251 year ago
MACD: Sell SignalJun 13, 20251 year ago
RSI: OverboughtJun 4, 20251 year ago
RSI: OverboughtJun 2, 20251 year ago
RSI: OverboughtMay 21, 20251 year ago
SMA: BullishMay 13, 20251 year ago
SMA: BearishMay 12, 20251 year ago
SMA: BullishMay 7, 20251 year ago
SMA: BearishMay 5, 20251 year ago
SMA: BullishMay 2, 20251 year ago
SMA: BearishApr 24, 20251 year ago
SMA: BullishApr 23, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
RSI: OversoldApr 3, 20251 year ago
SMA: BearishMar 20, 20251 year ago
SMA: BullishMar 7, 20251 year ago
SMA: BearishMar 6, 20251 year ago
MACD: Sell SignalFeb 27, 20251 year ago
RSI: OverboughtFeb 19, 20251 year ago
MACD: Buy SignalDec 30, 20241 year ago
RSI: OversoldDec 24, 20241 year ago

Key statistics

Market cap
7.71M
Enterprise value
9.10M
Trailing P/E
0.00
Forward P/E
13.34
PEG ratio
0.00
Price / sales
0.46
Price / book
0.51
EPS (TTM)
-1.81
Beta
1.42
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-22.90%
Revenue (TTM)
16.72M
Revenue growth
25.70%
Free cash flow
-894.75K
Total cash
1.28M
Total debt
1.17M
Return on equity
-29.22%
Shares outstanding
1.48M
Short % of float
0.35%
50-day average
6.13
200-day average
5.98

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PRPO Revenue — quarterly 7.02M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PRPO Net income — quarterly -219.00K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PRPO EPS — quarterly -0.12
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

PRPO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2024Sep 1, 20240.00-0.42——
Aug 13, 2024Jun 1, 20240.00-0.83——
May 14, 2024Mar 1, 20240.00-1.46——
Mar 29, 2024Dec 1, 20230.00-0.41——
Nov 13, 2023Sep 1, 20230.00-1.04——
Aug 11, 2023Jun 1, 20230.00-1.80——

About Precipio, Inc.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States

News

Your note

Sign in to keep a note on PRPO — it syncs with the Stock Master app.

Insider holders

PRPO insider holders
InsiderRelationLatest transactionDateShares held
ANDREWS RONALD ASBURYDirectorStock Award(Grant)Oct 14, 202411,128
COHEN DAVID SETHDirectorStock Award(Grant)Oct 14, 202447,560
COSSMAN JEFFREY M.D.DirectorStock Award(Grant)Oct 14, 202412,312
DANIELI ILANChief Executive OfficerPurchaseJan 2, 202357,046
FISHER DOUGLAS CARL M.D.DirectorStock Award(Grant)Oct 26, 20235,572
LAPORTE KATHLEEN DDirectorStock Award(Grant)Apr 14, 202410,071

Institution ownership

PRPO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.1.95%28,912150.38KSep 29, 2024
Vanguard Group Inc1.19%17,64591.78KSep 29, 2024
Geode Capital Management, LLC0.98%14,45875.20KSep 29, 2024
Wells Fargo & Company0.04%5502.86KSep 29, 2024
Tower Research Capital LLC (TRC)0.04%6113.18KSep 29, 2024
Citigroup Inc.0.03%4702.44KSep 29, 2024

Fund ownership

PRPO fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund1.19%17,64591.78KSep 29, 2024
Fidelity Extended Market Index Fund0.48%7,15437.21KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.21%3,09716.11KOct 30, 2024
Fidelity Total Market Index Fund0.13%1,8799.77KOct 30, 2024
Fidelity Series Total Market Index Fund0.12%1,7529.11KOct 30, 2024
Advertisement